CLASS II ONGOING Drug recall · Reported 28 Aug 2024 · FDA Enforcement Report

Timolol Maleate Ophthalmic Solution recalled by FDC

FDC is recalling Timolol Maleate Ophthalmic Solution USP, 5%, distributed nationwide in the US. The recall was initiated on 12 Aug 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: a) 083K063, Exp 10/31/2025; b) 083I091, Exp 08/31/2025.
NDC64980-513, 64980-514
UPC0364980513050
Quantity recalled176,784 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0642-2024
FDA event ID
95140
Recalling firm
FDC, Aurangabad, Maharashtra State
Manufacturer
Rising Pharma Holdings, Inc.
Classification
Class II
Status
Ongoing
Recall initiated
12 Aug 2024
FDA classified
22 Aug 2024
Reported
28 Aug 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Drug class
Eye Drops

Timeline

12 Aug 2024Recall initiated by company
22 Aug 2024Classified by FDA+10 days
28 Aug 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey

Where it was distributed

Nationwide U.S.A.

Nationwide

Questions about this recall

Is Timolol Maleate Ophthalmic Solution USP, 5% recalled?

Yes. FDC recalled Timolol Maleate Ophthalmic Solution USP, 5% on 12 Aug 2024. The recall is Class II and its status is Ongoing. Recall number D-0642-2024.

Why was it recalled?

Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Which lots are affected?

Lot #: a) 083K063, Exp 10/31/2025; b) 083I091, Exp 08/31/2025.

Where was it sold?

Nationwide U.S.A.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from FDC

All 11

Other Timolol recalls

All 11